Increased Hepatitis A cases in several European countries
A higher than expected number of cases of hepatitis A have been reported in several European countries between January and May 2025.
According to a report published by the European Centre for Disease Prevention and Control, more than 2000 cases have been reported in four countries, Austria (87), Czechia (600), Hungary (641) and Slovakia (880).
The report also provided a risk assessment stating that most of the cases were in high-risk groups, including those who were homeless, children living in disadvantaged areas and those using drugs.
They concluded the risk to the wider community and travellers remained low. However, this assessment may underestimate the unique risks faced by travellers.
Travel specific risks and food safety
Although the overall risk is considered low, travellers often face different conditions than residents, particularly when it comes to food safety.
Most of Europe has a good public health system where water and sanitation can be trusted. The risk of hepatitis A would be low in situations where the individual is mostly responsible for the preparation and provision of their own food. This is the case for residents but not for travellers.
Travellers are very dependent on others for meals and hepatitis A outbreaks are commonly related to food handlers or contaminated food. For example, a previous case in California was directly linked to a food handler, reinforcing the importance of caution while travelling.
A recent investigation by the UK Health Security Agency also identified two clusters of hepatitis A that are likely linked to contaminated food products, highlighting that such risks are not limited to lower income countries.
Hepatitis A in Australia
We also view the risk of hepatitis A to be low in urban Australia.
Hepatitis A is not given under the childhood immunisation program despite 200 to 300 cases annually. During the COVID-19 pandemic, only 50 to 70 cases were notified during the years when our borders were closed. Since the borders were opened, the numbers have returned to the same level with 137 cases being reported year to date, 20 May 2025 and more than 240 over the previous 12 months.
It is then reasonable to assume most cases come from overseas travel.
Reconsidering routine Hepatitis A vaccination
Given these patterns of transmission and the reliance on others for food while travelling, vaccination deserves stronger consideration.
It might also be reasonable to consider hepatitis A vaccine as a routine vaccine for travel rather than a recommended vaccine for a particular location.
In the United States the vaccine is a routine childhood vaccination. The first dose is given in the second year of life and a booster after 6 months. I believe it should be a childhood vaccine in Australia as well.
Hepatitis A is not a benign disease. While it is generally accepted that it might go unnoticed in very young children, it does have a mortality rate in older individuals. Convalescence after a bout of hepatitis A can also be prolonged. It might significantly change your memories of an overseas trip.
Immunity and long term protection
Hepatitis A is a common “growing up disease” in many low and low middle-income countries where public health infrastructure is poor. The child develops his/her immunity early in life and maintains this immunity over a lifetime, much in the same way as most individuals born before the 1960’s in Australia became naturally immune to chickenpox, measles, mumps and rubella.
Natural immunity to hepatitis A would not be common in those growing up in countries with a well-developed public health infrastructure.
With a safe and effective vaccine available since the early 1990s, and just two doses needed for long term immunity, hepatitis A vaccination represents a simple yet powerful safeguard - particularly for travellers.


